SimiTree Strengthens Southeast Sales with Appointment of Don Frolo as Business Development Executive
| RCMDelisted Stock | USD 14.31 0.01 0.07% |
About 55% of R1 RCM's investor base is interested to short. The analysis of overall sentiment of trading R1 RCM Inc stock suggests that many investors are impartial at this time. R1 RCM's investing sentiment overview a quick insight into current market opportunities from investing in R1 RCM Inc. Many technical investors use R1 RCM Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
RCM |
Hamden, CT, June 26, 2024 -- SimiTree, the industry leader in tech-enabled specialty revenue cycle management , coding, professional services, data analytics, and talent management resources for post-acute and behavioral health organizations, announces the appointment of Don Frolo as Business Development Executive for the Southeast. Don brings over two decades of proven success in the healthcare and IT sales industry. His career is marked by a consistent ability to exceed s
Read at finance.yahoo.com
 |
R1 RCM Fundamental Analysis
We analyze R1 RCM's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of R1 RCM using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of R1 RCM based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
R1 RCM is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
R1 RCM Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with R1 RCM stock to make a market-neutral strategy. Peer analysis of R1 RCM could also be used in its relative valuation, which is a method of valuing R1 RCM by comparing valuation metrics with similar companies.
Peers
R1 RCM Related Equities
| HCAT | Health Catalyst | 0.14 |
| ||
| SLP | Simulations Plus | 0.42 |
| ||
| DH | Definitive Healthcare | 0.47 |
| ||
| HSTM | HealthStream | 0.94 |
| ||
| FORA | Forian | 0.96 |
| ||
| HQY | HealthEquity | 1.14 |
| ||
| CERT | Certara | 1.47 |
| ||
| PRVA | Privia Health | 1.54 |
| ||
| EVH | Evolent Health | 1.85 |
| ||
| NRC | National Research | 2.19 |
|
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in RCM Stock
If you are still planning to invest in R1 RCM Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the R1 RCM's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |